Impairment of lipid metabolism due to deficiency of pyridoxal-5-phosphate and/or activated immune system: Its interpretation

Pteridines

Volumn 11, Issue 4, 2000, Pages 107-120

  Rudzite, V ^a   Jurika, E ^a   Jager M ^a   Fuchs, D ^a  

^a UNIVERSITY OF LATVIA   (Latvia)

Author keywords

5,6,7,8 Tetrahydrobiopterin; Cholesterol; Fatty acids; Homocysteine; Homocystine; Kynurenine; Neopterin; Noradrenalin; Phospholipid classes; Phospholipids; Pyridoxal 5 Phosphate; Triglycerol; Tryptophan

Indexed keywords

CHOLESTEROL; HOMOCYSTEINE; KYNURENINE; LIPID; NEOPTERIN; NORADRENALIN; PHOSPHOLIPID; POLYUNSATURATED FATTY ACID; PYRIDOXAL 5 PHOSPHATE; TETRAHYDROBIOPTERIN; TRYPTOPHAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CELL CYCLE; CELL MEMBRANE FLUIDITY; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; IMMUNE SYSTEM; LIPID COMPOSITION; LIPID METABOLISM; MALE; NONHUMAN; PHOSPHOLIPID SYNTHESIS; PRIORITY JOURNAL; RAT;

EID: 0034449999     PISSN: 09334807     EISSN: None     Source Type: Journal    
DOI: 10.1515/pteridines.2000.11.4.107     Document Type: Article

References (69)

1. Risk factors for atherosclerosis in proper perspectives
2. Review of serum lipids and lipoproteins in risk-assessment of coronary heart disease
3. High density lipoproteins and the problem of atherosclerosis
4. Some questions about pathogenesis of atherosclerosis
5. Anatomy of ischemic heart
6. Anatomy of hypertonic disease
7. Plasma pyridoxal-5-phosphate level as a risk index for coronary artery disease
8. Plasma homocysteine and cardiovascular disease
9. Promotion of vascular smooth muscle cell growth by homocysteine: A link to atherosclerosis
10. The determination of kynurenine in plasma
11. Tryptophan metabolism in humans; perspectives and predictions
12. Soluble products of immune activation: Neopterin
13. Immunological aspects of dilated cardiomyopathy
14. Synthesis and secretion of biliary phospholipids in man
15. A simple method for isolation and purification of total lipids from animal tissue
16. Untersuchung zur richtigkeit der prezipitation von lipoprotein mit phosphowolframsäure/MgCl bei der routinemässigen bestimung der HDL-Cholesterinkonzentration
17. Bestimmung des anorganischen phosphors nach Urbach - Raabe (modifiziert)
18. Induction of indoleamine 2, 3- dioxygenase in mouse lung during vires infection
19. Neopterin
20. Influence of kynurenine, neopterin, noradrenalin and pyridoxal-5-phosphate on cholesterol and phospholipid biosynthesis in vitro
21. The effect of subnormal vitamin B6 status on homocysteine metabolism
22. Bitamin B6 (pyridoxine)
23. Biochemistry of tryptophan in health and disease
24. Arteriosclerotic, dental and hepatic lesions in pyridoxine deficient monkeys
25. Lipid-membrane interactions and the pathogenesis of ischemic damage in myocardium
26. The role of phospholipids in the Ca++ binding of isolated sarcolemna
27. Effect of membrane lipid composition on mobility of lymphocyte surface immunoglobulins
28. Dynamics of membrane fatty acids during lymphocyte by mitogens
29. Abnormal fatty acid- composition of plasma and platelets in patients with acute myocardial infarction
30. Erythrocyte membrane cholesterol and phospholipid composition in hypertensives vs normotensives
31. Erythrocyte membrane cholesterol and phospholipid composition in hypertensives vs normotensives
32. Selenium status, fatty acids, antioxidant vitamins and aging
33. The relationship between kynurenine and arterial blood pressure
34. Bradyarrythmias and myocardial cell failure induced by kynurenine
35. Serum kynurenine and neopterin concentrations in patient with cardiomyopathy
36. Patterns of serological markers for cellular immune activation in patients with dilated cardiomyopathy and chronic myocarditis
37. Stimulated cellular immune system in patients with congestive heart failure
38. Elevated serum neopterin levels in atherosclerosis
39. Increased concentration of neopterin in carotid atherosclerosis
40. Approach to define "normal aging" in man. Immune function, serum lipids, lipoproteins and neopterin level
41. Importance of tryptophan pyrrolase and aromatic acid decarboxylase in the catabolism of tryptophan
42. The conversion of tryptophan to kynurenine in the liver. The coupled tryptophan peroxidase - Oxidase system forming formylkynurenine
43. The influence of tryptophan, serotonin, kynurenine and corticosteroids on activity of tryptophanpyrrolase, 5-hydroxytrytophan decarboxylase and catalase in rat liver
44. Complexity of in vivo induction of tryptophan oxygenase and tyrosine aminotransferase: Effect of tryptophan metabolites
45. Tryptophan pyrrolase of rabbit intestine (D- and L- tryptophan clearing enzyme or enzymes)
46. Interferon induced tryptophan metabolism by inducing pulmonary indolamine 2, 3-dioxygenase: Its possible occurance in cancer patients
47. Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon gamma
48. Pteridines and lipid metabolism
49. The changes in heart function, metabolism and ultrastructure due to experimentally induced cardiomyopathy
50. Drag induced damages in cardiovascular system
51. Impaired homocysteine metabolism in early onset cerebral and peripheral occlusive arterial diseases
52. Hyperhomocysteinemia: A common and easily reversible risk factor for occlusive atherosclerosis
53. A prospective study of plasma homocysteine and risk of myocardial infarction in U S physicians
54. Promotion of vascular smooth muscle cell growth by homocysteine: A link to atherosclerosis
55. Die wirkung von tryptophan auf die leukozytenzahl
56. Die wirkung von tryptophan auf das blutbild
57. The influence of tryptophan on blood leukocyte count in leukopenia
58. Studies on the influence of tryptophan and related compounds on hepatic polyribosomes and protein synthesis in the rat
59. Tryptophan binding to nuclear membrane receptor
60. Tetrahydrobiopterin metabolism in cell death by apoptosis
61. Treatment of mild hyperhomocycteinemia in vascular disease patients